These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25730182)

  • 41. New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation.
    Jöris M; Pustjens E; Mengling T; Fechter M; Wiersum-Osselton J; Bokhorst A; Foeken L
    Cell Tissue Bank; 2021 Jun; 22(2):191-197. PubMed ID: 32902671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
    Ballen KK; King RJ; Chitphakdithai P; Bolan CD; Agura E; Hartzman RJ; Kernan NA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):2-7. PubMed ID: 18721774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation.
    Petersdorf EW
    Bone Marrow Transplant; 2010 May; 45(5):807-10. PubMed ID: 20190834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system].
    Atsuta Y; Suzuki R; Yoshimi A; Gondo H; Tanaka J; Hiraoka A; Kato K; Tabuchi K; Tsuchida M; Morishima Y; Mitamura M; Kawa K; Kato S; Nagamura T; Takanashi M; Kodera Y
    Rinsho Ketsueki; 2007 Nov; 48(11):1462-9. PubMed ID: 18080503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.
    Bolan CD; Hartzman RJ; Perry EH; Trainor L; Miller J; Miller R; Hanley L; Chitphakdithai P; King RJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):23-8. PubMed ID: 18721777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The EBMT activity survey: 1990-2010.
    Passweg JR; Baldomero H; Gratwohl A; Bregni M; Cesaro S; Dreger P; de Witte T; Farge-Bancel D; Gaspar B; Marsh J; Mohty M; Peters C; Tichelli A; Velardi A; de Elvira CR; Falkenburg F; Sureda A; Madrigal A;
    Bone Marrow Transplant; 2012 Jul; 47(7):906-23. PubMed ID: 22543746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey.
    Arat M; Arpaci F; Ertem M; Gürman G;
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S142-S145. PubMed ID: 18724290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The US National Marrow Donor Program role in unrelated donor hematopoietic cell transplantation.
    Confer D; Robinett P
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S3-S5. PubMed ID: 18724295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Information technology and the role of WMDA in promoting standards for international exchange of hematopoietic stem cell donors and products.
    Maiers M; Bakker JN; Bochtler W; Eberhard HP; Marsh SG; Müller C; Rist HG;
    Bone Marrow Transplant; 2010 May; 45(5):839-42. PubMed ID: 20190838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases.
    Anderlini P; Rizzo JD; Nugent ML; Schmitz N; Champlin RE; Horowitz MM; ;
    Bone Marrow Transplant; 2001 Apr; 27(7):689-92. PubMed ID: 11360107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Japan Marrow Donor Program, the Japan Cord Blood Bank Network and the Asia Blood and Marrow Transplant Registry.
    Kodera Y
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S6. PubMed ID: 18724304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transplant registries: guiding clinical decisions and improving outcomes.
    Horowitz MM; Loberiza FR; Bredeson CN; Rizzo JD; Nugent ML
    Oncology (Williston Park); 2001 May; 15(5):649-59; discussion 663-4, 666. PubMed ID: 11396358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endorsing the enrolment of transplantation centers into the hematopoietic stem cell donor registries: An Indian perspective.
    Raturi M; Das K; Dhiman Y; Kala M; Bhasin S
    Transfus Clin Biol; 2023 May; 30(2):175-176. PubMed ID: 36228970
    [No Abstract]   [Full Text] [Related]  

  • 54. Goals and activities of the WMDA. World Marrow Donor Association.
    Gahrton G
    Int J Hematol; 2002 Aug; 76 Suppl 1():384-5. PubMed ID: 12430887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry.
    Michallet M; Sobh M; Milligan D; Morisset S; Niederwieser D; Koza V; Ruutu T; Russell NH; Verdonck L; Dhedin N; Vitek A; Boogaerts M; Vindelov L; Finke J; Dubois V; van Biezen A; Brand R; de Witte T; Dreger P;
    Leukemia; 2010 Oct; 24(10):1725-31. PubMed ID: 20703257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.
    Rüesch M; Amar El Dusouqui S; Buhrfeind E; Buser A; Chalandon Y; Frey BM; Güngör T; Holbro A; Huguet S; Infanti L; Nair G; Nicoloso G; Passweg JR; Schanz U; Tiercy JM; Widmer I; Zeilhofer U; Zurkinden L; Halter JP
    Bone Marrow Transplant; 2022 Jun; 57(6):918-924. PubMed ID: 35379914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alternative donor transplant of benign primary hematologic disorders.
    Tolar J; Sodani P; Symons H
    Bone Marrow Transplant; 2015 May; 50(5):619-27. PubMed ID: 25665040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of KIRs and KIR ligands in hematopoietic transplantation.
    Velardi A
    Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic transplantation for aplastic anemia.
    Eapen M
    Hematology; 2012 Apr; 17 Suppl 1():S15-7. PubMed ID: 22507769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.